Salt Lake City, UT - Aciont Inc. announces that John Higuchi, the company’s chief executive officer, will present at the upcoming IN3 East medical device conference at the Westin Copley Place Hotel in Boston, MA on Thursday, June 10, 2010, 3:10PM EDT. The meeting is hosted by Elsevier Business Intelligence.
The presentation will provide updates on the company’s ophthalmic non-invasive, controlled and sustained release technologies and relevant products in development addressing sight threatening diseases such as severe uveitis, diabetic macular edema, diabetic retinopathy and age-related macular degeneration.
Elsevier reports that the IN3 East conference is the largest East coast strategic partnership conference for medical device companies due to the large number of venture capital firms and medical technology companies that gather there to present their latest innovations and investment opportunities.
--
Aciont Inc. is a specialty biopharmaceutical company endeavoring to become the world leader in commercializing localized, non-invasive (topical passive diffusion-based and iontophoretic)
